glutathione iv dose How Often Can You Get a Drip? How Much is Too Much?

PMID: 39204186

The trial proceeded without reported toxicity, and no lethal dose threshold (LD1) was ever established in subsequent safety testing meaning researchers administering the compound could not find a dose that caused death in even 1% of test subjects across the animal model safety work that preceded and followed the human study

However, while early findings are promising, more robust clinical research is needed to confirm these effects.

Epidemiologic studies have raised the possibility of an association between PPI therapy and multiple potential adverse events, including osteoporosis, pneumonia, dementia, and chronic kidney insufficiency

Similarly, evidence concerning potential drugpeptide interactions is largely unavailable

Clinical pharmacology: advances and applications